However, our data demonstrating higher levels of secreted LCN2 in IBC vs non‐IBC cell lines and showing significant inhibition of key IBC tumor features such as tumor emboli/skin invasion in LCN2‐silenced tumors suggest that LCN2 may exert its influence via an IBC‐specific mechanism. The gene discussed is LCN2; the disease is neoplasm.